Related Experiment Videos
Endothelins in chronic liver disease
1Department of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, Denmark.
Scandinavian Journal of Clinical and Laboratory Investigation
|October 1, 1996
Summary
Endothelins (ETs) are activated in chronic liver disease, particularly cirrhosis. Elevated ET-1 and ET-3 levels correlate with disease severity, fluid retention, and renal dysfunction in cirrhotic patients.
Area of Science:
- Cardiovascular Research
- Hepatology
- Endocrinology
Background:
- Chronic liver disease, especially cirrhosis, involves complex circulatory and neurohumoral disturbances.
- The role of endothelins (ETs), vasoactive polypeptides, in the pathophysiology of cirrhosis is an area of active investigation.
Purpose of the Study:
- To review recent advancements in understanding the endothelin system's involvement in chronic liver disease.
- To explore the relationship between ET-1, ET-3, and the circulatory and neurohumoral dysregulation characteristic of cirrhosis.
Main Methods:
- Review of recent studies on endothelin system activation in cirrhotic patients.
- Analysis of circulating ET-1 and ET-3 levels in relation to disease severity and complications.
- Investigation of ET-1 synthesis in liver biopsies and the hepatosplanchnic system's contribution to circulating endothelins.
Main Results:
- The endothelin system is significantly activated in most patients with cirrhosis.
- Circulating ET-1 and ET-3 levels positively correlate with cirrhosis severity, fluid retention, and functional renal failure.
- The hepatosplanchnic system is a major source of ET-1 and ET-3 spillover, linked to portal venous hypertension and systemic hemodynamic disturbances.
Conclusions:
- The endothelin system plays a crucial role in the pathophysiology of chronic liver disease and cirrhosis.
- ETs may act as systemic regulators in cirrhosis, similar to other vasopressive systems like renin-angiotensin-aldosterone.